Name
Role
GMC number
If it ain't broke, don't fix it
Bert Lance
My current role
I am the clinical lead of the nuclear medicine service in the department of radiology at Addenbrooke's Hospital.
Our service provides clinical tests for a variety of diseases and clinical conditions using radioactive drugs with imaging and non-imaging based methods.
We are also involved in delivering radionuclide based therapies in a small number of specific clinical conditions.
Our service also provides support for Bone Density scanning (Dual X-ray absorptiometry - DXA).
Previous history
I completed my medical training in Italy in 1990, followed by specialty training in nuclear medicine in 1994.
I worked in the United States from 1994 to 1998 as a clinical research fellow and associate at the National Institutes of Health, Bethesda, Maryland.
I worked in nuclear medicine for the National Research Council in Napoli, Italy from 1998 to 2003 with an honorary consultant role in the University Hospital.
From 2003 to 2016, I worked as a nuclear medicine and radionuclide therapy consultant in the National Cancer Institute in Napoli, Italy.
Since 2016 I have been a consultant at Addenbrooke's Hospital.
Memberships and accreditations
I am member of the:
- European Association of Nuclear Medicine, for which I am also a member of the Drug Development Committee
- US Society of Nuclear Medicine and Molecular Imaging
- Society of Radiopharmaceutical Sciences (SRS)
- British Nuclear Medicine Society.
Personal interests
My interests include my family, outdoor activities cycling, gardening and walking.
I also enjoy traveling, mostly to Italy to spend time with extended family and visit favourite sea, mountain and countryside holiday locations.
Publications
-
Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma Model
-
Detection limit of 89 Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI
-
The emerging role of cell surface receptor and protein binding radiopharmaceuticals in cancer diagnostics and therapy
-
Novel Approach to Imaging Active Takayasu Arteritis Using Somatostatin Receptor Positron Emission Tomography/Magnetic Resonance Imaging
-
F-FDG PET/CT Is an Early Predictor of Pathologic Tumor Response and Survival After Preoperative Radiochemotherapy with Bevacizumab in High-Risk Locally Advanced Rectal Cancer